PREVALENCE AND RISK FACTORS ASSOCIATED WITH VIRAL HEPATITIS B AND C AMONG IMMUNOCOMPROMISED PATIENTS Case study: Kibuye Referral Hospital

dc.contributor.author	KAMANYANA, Drocelle
dc.contributor.author	MUKESHIMANA, James
dc.date.accessioned	2023-10-30T11:05:33Z
dc.date.available	2023-10-30T11:05:33Z
dc.date.issued	2023-08
dc.identifier.citation	APA	en_US
dc.identifier.uri	https://repository.kp.ac.rw/xmlui/handle/123456789/175
dc.description	1.0 INTRODUCTION This chapter one is concerned with the background of the study, problem statement, purpose of the study, objective of the study, research question, significance of the study, limitation of the study, and scope of the study about the prevalence of viral hepatitis B and C among immunocompromised patients.	en_US
dc.description.abstract	Globally hepatitis B virus (HBV) is enormous, with 257 million people chronically infected each year and over 880,000 deaths worldwide. In sub-Saharan Africa where is belonging Rwanda, approximately 60 million people are chronically infected with the hepatitis B virus (HBV) and 10. 2 million people chronically infected with hepatitis C virus (HCV).	en_US
dc.description.sponsorship	HITAYEZU Elysée	en_US
dc.language.iso	en	en_US
dc.publisher	Kibogora Polytechnic	en_US
dc.subject	VIRAL HEPATITIS B	en_US
dc.subject	IMMUNOCOMPROMISED PATIENTS	en_US
dc.title	PREVALENCE AND RISK FACTORS ASSOCIATED WITH VIRAL HEPATITIS B AND C AMONG IMMUNOCOMPROMISED PATIENTS Case study: Kibuye Referral Hospital	en_US
dc.type	Thesis	en_US

Files in this item

Name: AfterDefense-Phase ...

Size: 111.1Kb

Format: Microsoft Word 2007

Biomedical laboratory science
Biomedical laboratory Science also known as Medical Laboratory Science (Laboratory Medicine) is the branch of medical science specifically concerned with the laboratory diagnosis and monitoring of disease.